<?xml version="1.0" encoding="UTF-8" ?>

    <journal>
    <language>en</language>
    <journal_id_issn>2008-2835</journal_id_issn>
    <journal_id_issn_online>2008-4625</journal_id_issn_online>
    <journal_id_pii></journal_id_pii>
    <journal_id_doi></journal_id_doi>
    <journal_id_isnet></journal_id_isnet>
    <journal_id_iranmedex>276</journal_id_iranmedex>
    <journal_id_magiran>5669</journal_id_magiran>
    <journal_id_sid>11181</journal_id_sid>
    <pubdate>
	    <type>gregorian</type>
	    <year>>2018</year>
	    <month>>April-June</month>
	    <day></day>
    </pubdate>
    <volume>10</volume>
    <number>2</number>
    <publish_type>online</publish_type>
    <publish_edition>1</publish_edition>
    <article_type>fulltext</article_type>
    <articleset>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed>29849987</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>Tumor Necrosis Factor-Alpha and Interleukin-6 Gene Polymorphisms in Iranian Patients with Ischemic Heart Failure</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;Background: Proinflammatory cytokines have been known to be elevated in patients with Chronic Heart Failure (CHF). Given the importance of proinflammatory cytokines in the context of the failing heart, the prevalence of Tumor Necrosis Factor-&amp;alpha; (TNF-&amp;alpha;), Interleukin (IL)-6 polymorphisms in patients with CHF was studied due to ischemic heart disease.&lt;br /&gt;
Methods: Forty three patients with ischemic heart failure were enrolled in this study and compared with 140 healthy individuals. The allele and genotype frequency of four Single Nucleotide Polymorphisms (SNPs) within the IL-6 (-174, nt565) and TNF-&amp;alpha; (-308, -238) genes were determined, using Polymerase Chain Reaction with Sequence-Specific Primers (PCR-SSP) assay.&lt;br /&gt;
Results: The frequency of the TNF-&amp;alpha; (-238) A/A genotype was significantly higher in patients comparing to controls (p=0.043), while TNF-&amp;alpha; G/A genotype at the same position decreased significantly, in comparison with controls (p=0.018). The most frequent haplotype for TNF-&amp;alpha; was A/A in the patient group in comparison with controls (p=0.003). There was no significant difference in allele and genotype frequencies of IL-6 at positions -174 and nt565, and TNF-&amp;alpha; at position -308.&lt;br /&gt;
Conclusion: Certain alleles, genotypes, and haplotypes in TNF-&amp;alpha;, but not IL-6, gene were overrepresented in patients with ischemic heart failure, which may, in turn, predispose individuals to this disease.&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Genes, Heart failure, Interleukin-6, Tumor necrosis factor-alpha</keyword>
	<start_page>105</start_page>
	<end_page>109</end_page>
	<web_url>https://www.ajmb.org/En/Article.aspx?id=309</web_url>
    <pdf_url>https://www.ajmb.org/PDF/En/FullText/309.pdf</pdf_url>
	<author_list><author><first_name>Mona</first_name><middle_name></middle_name><last_name>Hedayat</last_name><suffix></suffix><affiliation>Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Boston, MA, USA</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>1229</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Mohammad Jafar</first_name><middle_name></middle_name><last_name>Mahmoudi</last_name><suffix></suffix><affiliation>Division of Cardiology, Department of Internal Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>1230</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Mohammad</first_name><middle_name></middle_name><last_name>Taghvaei</last_name><suffix></suffix><affiliation>Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>1231</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Ebrahim</first_name><middle_name></middle_name><last_name>Nematipour</last_name><suffix></suffix><affiliation>Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>1232</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Elham</first_name><middle_name></middle_name><last_name>Farhadi</last_name><suffix></suffix><affiliation>Hematology Department, Faculty of Allied Medical Science, Iran University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>1057</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Nilufar</first_name><middle_name></middle_name><last_name>Esfahanian</last_name><suffix></suffix><affiliation>Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>1233</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Maryam</first_name><middle_name></middle_name><last_name>Mahmoudi</last_name><suffix></suffix><affiliation>Dietitian and Nutrition Experts Team (DiNET), Universal Scientific Education and Research Network (USERN), Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>1234</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Maryam</first_name><middle_name></middle_name><last_name>Sadr</last_name><suffix></suffix><affiliation>Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>1235</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Keramat</first_name><middle_name></middle_name><last_name>Nourijelyani</last_name><suffix></suffix><affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>1236</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Ali Akbar</first_name><middle_name></middle_name><last_name>Amirzargar</last_name><suffix></suffix><affiliation>Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>179</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Nima</first_name><middle_name></middle_name><last_name>Rezaei</last_name><suffix></suffix><affiliation>Medical Genetics Network (MeGeNe), Universal Scientific Education and Research Network (USERN), Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>186</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

</articleset>
</journal>

